← Leaderboards
Leo E Otterbein
University Of Pittsburgh At Pittsburgh
$8,123,287
Attributed
$13,824,873
Total exposure
11
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,824,873 · 11
By mechanism
R01$10,664,590 · 5
R44$1,497,651 · 1
R41$1,133,192 · 3
R56$304,500 · 1
R43$224,940 · 1
Top collaborators
- Edward Gomperts10 shared
- Binghe Wang9 shared
- Chalet Tan5 shared
- Mark P De Caestecker4 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Henry E Wang$15,583,055
- Daolin Tang$7,044,772
- Susan Marguerite Shea$515,117
- Michael R Pinsky$13,601,966
- Jie Fan$6,254,496
Others in their field
Top investigators on “Carbon Monoxide”
- Augustine M Choi · Weill Medical Coll Of Cornell Univ$20,003,575
- Jennifer L Peel · Colorado State University$10,917,915
- Robert M Elashoff · John Wayne Cancer Institute$10,394,671
- Thomas F Clasen · Emory University$10,365,551
- William N Checkley · Universidad Peruana Cayetano Heredia$10,365,551
- Stephen W Ragsdale · University Of Nebraska Lincoln$10,164,754
Research focus
Carbon MonoxideIn VivoLiteratureDoseHemeAnimal ModelPreventInnovationPre-ClinicalNitric OxideAnimalsGasesBaseKineticsInflammationOralPropertyModalitySafetyDrug KineticsToxic EffectImproved OutcomeReperfusion InjuryFormulation
Grant awards (34)
Early-Stage Preclinical Validation of Carbon Monoxide Prodrugs for Acute Kidney Injury$705,716
R01 · FY2025 · DK
Early-Stage Preclinical Validation of Carbon Monoxide Prodrugs for Acute Kidney Injury$678,976
R01 · FY2024 · DK
Examining Carbon Monoxide to Treat Inflammatory Conditions using Experimental Colitis Models$708,873
R01 · FY2023 · DK
Early-Stage Preclinical Validation of Carbon Monoxide Prodrugs for Acute Kidney Injury$707,586
R01 · FY2023 · DK
Low Dose Oral Carbon Monoxide Therapeutic for Virus-Induced Lung Injury$299,894
R41 · FY2023 · AI
Early-Stage Preclinical Validation of Carbon Monoxide Prodrugs for Acute Kidney Injury$750,347
R01 · FY2022 · DK
Examining Carbon Monoxide to Treat Inflammatory Conditions using Experimental Colitis Models$708,873
R01 · FY2022 · DK
Low Dose Oral Carbon Monoxide Therapeutic for Virus-Induced Lung Injury$299,894
R41 · FY2022 · AI
Examining Carbon Monoxide to Treat Inflammatory Conditions using Experimental Colitis Models$708,873
R01 · FY2021 · DK
HBI-002 to Treat Ulcerative Colitis$75,058
R41 · FY2021 · DK
HBI-002 to Prevent Anthracycline-Related Cardiotoxicity$16,896
R41 · FY2021 · HL
Examining Carbon Monoxide to Treat Inflammatory Conditions using Experimental Colitis Models$707,948
R01 · FY2020 · DK
HBI-002 to Prevent Anthracycline-Related Cardiotoxicity$222,338
R41 · FY2020 · HL
HBI-002 to Treat Ulcerative Colitis$219,112
R41 · FY2020 · DK
Examining Carbon Monoxide to Treat Inflammatory Conditions using Experimental Colitis Models$733,350
R01 · FY2019 · DK
HBI-002 to Treat Traumatic Injury$56,476
R43 · FY2019 · GM
HBI-002 to Treat Traumatic Injury$168,464
R43 · FY2018 · GM
HBI-002 to Treat Delayed Graft Function in Kidney Transplant$635,033
R44 · FY2017 · DK
HBI-002 to Treat Delayed Graft Function in Kidney Transplant$862,618
R44 · FY2016 · DK
Endogenous Gas Molecules As Transcription Factors$341,075
R01 · FY2012 · GM · contact PI
Endogenous Gas Molecules As Transcription Factors$341,075
R01 · FY2011 · GM · contact PI
HemeOxygenase-1 and Transplant Tolerance$304,500
R56 · FY2011 · AI · contact PI
Endogenous Gas Molecules As Transcription Factors$344,189
R01 · FY2010 · GM · contact PI
Endogenous Gas Molecules As Transcription Factors$345,600
R01 · FY2009 · GM · contact PI
Carbon Monoxide to Prevent Circulatory Collapse$402,977
R01 · FY2007 · HL · contact PI
Carbon Monoxide to Prevent Circulatory Collapse$415,013
R01 · FY2006 · HL · contact PI
Anti-Inflammatory Effects of Carbon Monoxide in the Lung$332,010
R01 · FY2006 · HL · contact PI
Carbon Monoxide to Prevent Circulatory Collapse$425,000
R01 · FY2005 · HL
Anti-Inflammatory Effects of Carbon Monoxide in the Lung$340,000
R01 · FY2005 · HL
Carbon Monoxide to Prevent Circulatory Collapse$308,129
R01 · FY2004 · HL
Anti-Inflammatory Effects of Carbon Monoxide in the Lung$289,583
R01 · FY2004 · HL
Carbon Monoxide to Prevent Circulatory Collapse$48,846
R01 · FY2004 · HL
Anti-Inflammatory Effects of Carbon Monoxide in the Lung$1
R01 · FY2004 · HL
Anti-Inflammatory Effects of Carbon Monoxide in the Lung$320,550
R01 · FY2003 · HL